Current Pharmaceutical Analysis : Impact Factor & More
eISSN: 1875-676XpISSN: 1573-4129
Share this on:
Key Metrics
CiteScore 
1.2
Impact Factor
< 5
SJR
Q4Biophysics
SNIP
0.31
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Pharmaceutical Analysis
Current Pharmaceutical Analysis Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Pharmaceutical Analysis ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Pharmaceutical Analysis
Analytical advances in the quantitative and qualitative determination of clonidine and methyldopa: A review
- 1 Jan 2026
- Current Pharmaceutical Analysis
The evolution and outlook of immunosuppressants: Mechanisms and clinical practice
- 1 Jan 2026
- Current Pharmaceutical Analysis
Stability of Ketamine-Xylazine-Butorphanol Formulation to Establish an Evidence-Based Beyond-Use Date
- 1 Jan 2026
- Current Pharmaceutical Analysis
Identification of key molecular targets and mechanism of action in acute kidney injury by integrating network pharmacology and molecular docking
- 1 Jan 2026
- Current Pharmaceutical Analysis
Advances in Electroanalytical Techniques for Pharmaceuticals and Biological Samples: Insights from the Last Decade
- 1 Jan 2026
- Current Pharmaceutical Analysis
Ferulic acid targets AKT1/STAT3/EGFR signaling to induce apoptosis and inhibit metastasis in gastric cancer cells
- 1 Jan 2026
- Current Pharmaceutical Analysis
Analytical advances in the quantitative and qualitative determination of clonidine and methyldopa: A review
- 1 Jan 2026
- Current Pharmaceutical Analysis
The evolution and outlook of immunosuppressants: Mechanisms and clinical practice
- 1 Jan 2026
- Current Pharmaceutical Analysis
Stability of Ketamine-Xylazine-Butorphanol Formulation to Establish an Evidence-Based Beyond-Use Date
- 1 Jan 2026
- Current Pharmaceutical Analysis
Identification of key molecular targets and mechanism of action in acute kidney injury by integrating network pharmacology and molecular docking
- 1 Jan 2026
- Current Pharmaceutical Analysis
Advances in Electroanalytical Techniques for Pharmaceuticals and Biological Samples: Insights from the Last Decade
- 1 Jan 2026
- Current Pharmaceutical Analysis
Ferulic acid targets AKT1/STAT3/EGFR signaling to induce apoptosis and inhibit metastasis in gastric cancer cells
- 1 Jan 2026
- Current Pharmaceutical Analysis
FAQs on Current Pharmaceutical Analysis
How long has Current Pharmaceutical Analysis been actively publishing? 
What is the publishing frequency of Current Pharmaceutical Analysis?
How many articles did Current Pharmaceutical Analysis publish last year?
What is the eISSN & pISSN for Current Pharmaceutical Analysis?
What is Citescore for Current Pharmaceutical Analysis?
What is SNIP score for Current Pharmaceutical Analysis?
What is the SJR for Current Pharmaceutical Analysis?
Who is the publisher of Current Pharmaceutical Analysis?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations